DrugPatentWatch Database Preview
TOTECT Drug Profile
or, see our see our flat-rate plans
Which patents cover Totect, and what generic alternatives are available?
This drug has twenty-two patent family members in sixteen countries.
The generic ingredient in TOTECT is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Summary for TOTECT
| International Patents: | 22 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 36 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,187 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TOTECT at DailyMed |
Pharmacology for TOTECT
| Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for TOTECT
Synonyms for TOTECT
| (+)-Razoxane hydrochloride |
| (S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione hydrochloride |
| (S)-4,4'-(propane-1,2-diyl)bis(piperazine-2,6-dione) hydrochloride |
| 003D010 |
| 1263283-43-7 |
| 149003-01-0 |
| 2,6-Piperazinedione, 4,4'-((1S)-1-methyl-1,2-ethanediyl)bis-, hydrochloride (1:1) |
| 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, hydrochloride, (S)- |
| 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride |
| 5346058Q7S |
| AC-9014 |
| AC1OCF6D |
| ADR-529 |
| ADR-529 hydrochloride |
| AKOS015900046 |
| AN-7454 |
| AOB6763 |
| AOB6863 |
| API0005176 |
| AS-16976 |
| C11H16N4O4.HCl |
| Cardioxane |
| CHEBI:50224 |
| CHEMBL1200778 |
| CS-0767 |
| D07807 |
| Dexrazoxane (Hydrochloride) |
| Dexrazoxane (TN) |
| Dexrazoxane HCl |
| Dexrazoxane hydrochloride |
| Dexrazoxane hydrochloride [ORANGE BOOK] |
| Dexrazoxane hydrochloride [VANDF] |
| Dexrazoxane hydrochloride [WHO-DD] |
| DTXSID60164152 |
| FT-0700082 |
| HY-76201 |
| I14-10061 |
| ICRF 187 hydrochloride |
| ICRF-187 hydrochloride |
| KDX-0811 |
| MolPort-023-276-958 |
| Razoxane (+)-form hydrochloride [MI] |
| Razoxane hydrochloride, (S)- |
| s1222 |
| Savene |
| Savene (TN) |
| SCHEMBL18188 |
| TopoTect |
| Totect (TN) |
| UNII-5346058Q7S |
| UNII-BR9T89F617 component BIFMNMPSIYHKDN-FJXQXJEOSA-N |
| W-5214 |
| X5010 |
| Zinecard |
| Zinecard (TN) |
US Patents and Regulatory Information for TOTECT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinigen Hlthcare | TOTECT | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 022025-001 | Sep 6, 2007 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
International Patents for TOTECT
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Germany | 1162981 | ➤ Try a Free Trial |
| Spain | 2220424 | ➤ Try a Free Trial |
| China | 1346275 | ➤ Try a Free Trial |
| Japan | 2002539168 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
